All Stories
Anti-corruption crusader rattles India’s political class
NEW DELHI (Reuters) - From a shabby house in one of New Delhi's grimmest suburbs, a mild-mannered former tax official has launched a salvo of accusations of corruption involving some...
Anti-corruption crusader rattles India’s political class
NEW DELHI (Reuters) - From a shabby house in one of New Delhi's grimmest suburbs, a mild-mannered former tax official has launched a salvo of accusations of corruption involving some...
Analysis: India wins over markets, but now comes the hard part
NEW DELHI (Reuters) - India's Finance Minister P. Chidambaram exudes the self-confidence of a man who, in the eyes of India's cheerleading financial markets, can do little wrong. In the...
Analysis: India wins over markets, but now comes the hard part
NEW DELHI (Reuters) - India's Finance Minister P. Chidambaram exudes the self-confidence of a man who, in the eyes of India's cheerleading financial markets, can do little wrong. In the...
Insight: Punchups, kidnappings mar India’s efforts to privatize power
NEW DELHI (Reuters) - It is rough being an employee of Torrent Power Ltd in the Indian city of Agra. Furious residents regularly take staff of the power distributor hostage...
Insight: Punchups, kidnappings mar India’s efforts to privatize power
NEW DELHI (Reuters) - It is rough being an employee of Torrent Power Ltd in the Indian city of Agra. Furious residents regularly take staff of the power distributor hostage...
Indian PM drowned out in growing furor over “coalgate”
NEW DELHI (Reuters) - Indian lawmakers chanting "quit prime minister" drowned out Manmohan Singh on Monday as he sought to defend his government's role in an affair dubbed "coalgate" that...
Analysis: India poised to revive retail reform plan
NEW DELHI (Reuters) - Indian Prime Minister Manmohan Singh was overseas and his outgoing finance minister was clearing his desk last week as the government quietly began preparing the ground...
Probe uncovers serious problems with India’s drug regulator
NEW DELHI (Reuters) - India's main drug regulator has not been properly scrutinizing some drugs before approving them, and some of its officials are colluding with drug firms and medical...